Gary Ott

4.8k total citations
42 papers, 3.7k citations indexed

About

Gary Ott is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Gary Ott has authored 42 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 19 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Gary Ott's work include Immunotherapy and Immune Responses (18 papers), RNA Interference and Gene Delivery (10 papers) and Immune Response and Inflammation (9 papers). Gary Ott is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), RNA Interference and Gene Delivery (10 papers) and Immune Response and Inflammation (9 papers). Gary Ott collaborates with scholars based in United States, Italy and Japan. Gary Ott's co-authors include Derek T. O’Hagan, Gary Van Nest, Maylene Briones, Manmohan Singh, Ennio De Gregorio, Anja Seubert, Marc Dupuis, Donald M. McDonald, Gail L. Barchfeld and Mildred Ugozzoli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Gary Ott

42 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Ott United States 29 2.3k 1.5k 1.0k 649 309 42 3.7k
Reinhard Glück Switzerland 32 1.1k 0.5× 926 0.6× 1.3k 1.3× 666 1.0× 178 0.6× 81 2.8k
Mark A. Tomai United States 39 3.4k 1.5× 753 0.5× 1.5k 1.4× 531 0.8× 250 0.8× 80 5.1k
Michael J. McCluskie Canada 33 2.1k 0.9× 939 0.6× 1.1k 1.0× 686 1.1× 173 0.6× 82 3.6k
Sudhir Pai Kasturi United States 18 2.3k 1.0× 1.7k 1.1× 756 0.7× 524 0.8× 277 0.9× 22 3.9k
Nathalie Garçon Belgium 34 2.8k 1.2× 1.7k 1.1× 1.7k 1.7× 1.3k 2.0× 394 1.3× 67 5.3k
Sylvie Bertholet United States 37 2.5k 1.1× 1.5k 1.0× 1.8k 1.7× 1.3k 2.0× 161 0.5× 60 5.0k
Darrick Carter United States 38 1.2k 0.5× 1.2k 0.8× 1.4k 1.3× 793 1.2× 187 0.6× 110 4.0k
Giampietro Corradin Switzerland 44 3.5k 1.5× 3.0k 2.1× 924 0.9× 397 0.6× 616 2.0× 164 7.4k
Christian F. Ockenhouse United States 44 2.0k 0.9× 1.5k 1.0× 910 0.9× 680 1.0× 654 2.1× 91 5.7k
H. Snippe Netherlands 31 1.1k 0.5× 1.1k 0.7× 1.6k 1.6× 775 1.2× 234 0.8× 156 3.6k

Countries citing papers authored by Gary Ott

Since Specialization
Citations

This map shows the geographic impact of Gary Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Ott more than expected).

Fields of papers citing papers by Gary Ott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Ott. The network helps show where Gary Ott may publish in the future.

Co-authorship network of co-authors of Gary Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Ott. A scholar is included among the top collaborators of Gary Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Ott. Gary Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Hagan, Derek T., Gary Ott, Ennio De Gregorio, & Anja Seubert. (2012). The mechanism of action of MF59 – An innately attractive adjuvant formulation. Vaccine. 30(29). 4341–4348. 362 indexed citations
2.
Hou, Baidong, Philippe Saudan, Gary Ott, et al.. (2011). Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response. Immunity. 34(3). 375–384. 189 indexed citations
3.
Guiducci, Cristiana, Gary Ott, Jean H. Chan, et al.. (2006). Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. The Journal of Experimental Medicine. 203(8). 1999–2008. 306 indexed citations
4.
Marshall, Jason D., Christi Abbate, Priscilla Yee, et al.. (2004). Polymyxin B enhances ISS-mediated immune responses across multiple species. Cellular Immunology. 229(2). 93–105. 21 indexed citations
5.
Denis-Mize, Kimberly, Marc Dupuis, Manmohan Singh, et al.. (2003). Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Cellular Immunology. 225(1). 12–20. 63 indexed citations
6.
Ott, Gary. (2002). A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. Journal of Controlled Release. 79(1-3). 1–5. 53 indexed citations
7.
Singh, Manmohan, Gary Ott, Jina Kazzaz, et al.. (2001). Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA. Pharmaceutical Research. 18(10). 1476–1479. 92 indexed citations
8.
Briones, Maylene, Manmohan Singh, Mildred Ugozzoli, et al.. (2001). The Preparation, Characterization, and Evaluation of Cationic Microparticles for DNA Vaccine Delivery. Pharmaceutical Research. 18(5). 709–712. 54 indexed citations
9.
Dupuis, Marc, Kimberly Denis-Mize, Wendy Peters, et al.. (2001). Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. European Journal of Immunology. 31(10). 2910–2918. 96 indexed citations
10.
Dupuis, Marc, Kimberly Denis-Mize, Cheryl Goldbeck, et al.. (2000). Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice. The Journal of Immunology. 165(5). 2850–2858. 261 indexed citations
11.
Neidleman, Jason, Michael Vajdy, Mildred Ugozzoli, Gary Ott, & Derek T. O’Hagan. (2000). Genetically detoxified mutants of heat‐labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T‐cell responses against HIV‐1 gag‐p55. Immunology. 101(1). 154–160. 32 indexed citations
12.
Denis-Mize, Kimberly, Marc Dupuis, Mary Lee MacKichan, et al.. (2000). Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Therapy. 7(24). 2105–2112. 130 indexed citations
13.
Kazzaz, Jina, Jason Neidleman, Manmohan Singh, Gary Ott, & Derek T. O’Hagan. (2000). Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. Journal of Controlled Release. 67(2-3). 347–356. 94 indexed citations
14.
O’Hagan, Derek T., Cheryl Goldbeck, Mildred Ugozzoli, Gary Ott, & Rae Lyn Burke. (1999). Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs. Vaccine. 17(18). 2229–2236. 28 indexed citations
15.
Dupuis, Marc, Thomas J. Murphy, Deborah Higgins, et al.. (1998). Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection. Cellular Immunology. 186(1). 18–27. 130 indexed citations
16.
O’Hagan, Derek T., Gary Ott, & Gary Van Nest. (1997). Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Molecular Medicine Today. 3(2). 69–75. 67 indexed citations
17.
Prior, C., R A Knight, Manfred Herold, Gary Ott, & MA Spiteri. (1996). Pulmonary sarcoidosis: patterns of cytokine release in vitro. European Respiratory Journal. 9(1). 47–53. 62 indexed citations
18.
Ott, Gary, Gail L. Barchfeld, & Gary Van Nest. (1995). Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine. 13(16). 1557–1562. 106 indexed citations
19.
Burke, Rae Lyn, et al.. (1994). The Influence Of Adjuvant On The Therapeutic Efficacy Of A Recombinant Genital Herpes Vaccine. The Journal of Infectious Diseases. 170(5). 1110–1119. 51 indexed citations
20.
Stanberry, Lawrence R., Christopher J. Harrison, David I. Bernstein, et al.. (1989). Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: Factors influencing efficacy. Antiviral Research. 11(4). 203–214. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reinhard Glück Breakdown of academic impact, for papers by Mark A. Tomai Breakdown of academic impact, for papers by Michael J. McCluskie Breakdown of academic impact, for papers by Sudhir Pai Kasturi Breakdown of academic impact, for papers by Nathalie Garçon Breakdown of academic impact, for papers by Sylvie Bertholet Breakdown of academic impact, for papers by Darrick Carter Breakdown of academic impact, for papers by Giampietro Corradin Breakdown of academic impact, for papers by Christian F. Ockenhouse Breakdown of academic impact, for papers by H. Snippe
Rankless by CCL
2026